Insomnia occurs in more thatn 50% of the population at some time. It tends to occur more frequently with advancing age and is more prevalent to women than in men. Insomnia is the inability to obtain sleep of sufficient length or quality to produce refreshment upon awakening. It can manifest as difficulty falling asleep, difficulty remaining asleep, early morning awakening, or sleep that it not restorative.
Continued insomnia results in reduced productivity, increased risk of accidents, decreased productive behavior and increased risk of excessive alcohol (or other depressant) use. (Use of alcohol to induce sleep is counterproductive because even though it may induce sleep, it interferes with the stages of deep sleep that are important for refreshment and regenerative processes.)
Ambien
Ambien (Zolpidem) sleeping pills can be very effective in the short-term treatment of insomnia. Ambien (Zolpidem) can help you fall asleep, stay asleep, and not awaken prematurely.
Imovane
Zopiclone ( ZOP-i-klone) belongs to the group of medicines called central nervous system (CNS) depressants (medicines that make you drowsy or less alert). This medicine is used to treat insomnia (trouble in sleeping). Zopiclone helps you get to sleep faster and sleep through the night. In general, when sleep medicines are used every night for a long time, they may lose their effectiveness. In most cases, sleep medicines should be used only for short periods of time, such as 1 or 2 days, and generally for no longer than 1 or 2 weeks.
Lunesta
Lunesta is prescribed by doctors for short term treatment of sleep difficulties or insomnia. Lunesta is designed to give you a restful night's sleep with fewer interruptions. Lunesta not only helps most people fall asleep quickly, it helps you stay asleep all night long and wake up refreshed. Unlike other sleep aids, Lunesta does not cause you to feel drowsy the next day.
Rozerem
Rozerem is the first and only prescription sleep medication that has shown no evidence of abuse and dependence and, as a result, has not been designated as a controlled substance by the DEA. With the exception of Rozerem, all other prescription medications indicated for insomnia are classified as Schedule IV controlled substances by the DEA. Additionally, Rozerem is the first prescription insomnia medication with a new therapeutic mechanism of action in 35 years.
Sonata
Sonata (Zaleplon) is a new sleep aid on the market giving relief for millions from sleeplessness. Sonata has a shorter period of influence in the body and is beneficial for people who struggle to fall asleep but don't have trouble staying asleep.
